CD68 and breast cancer: In the TME of BC, LILRB1 was predominantly expressed by infiltrating CD68+ macrophages 333, and was also notably upregulated in NK cells, particularly in patients with invasive BC relative to healthy donors and individuals with noninvasive (in situ) lesions 334, 335.